FR2397401A1 - Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique - Google Patents

Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique

Info

Publication number
FR2397401A1
FR2397401A1 FR7821086A FR7821086A FR2397401A1 FR 2397401 A1 FR2397401 A1 FR 2397401A1 FR 7821086 A FR7821086 A FR 7821086A FR 7821086 A FR7821086 A FR 7821086A FR 2397401 A1 FR2397401 A1 FR 2397401A1
Authority
FR
France
Prior art keywords
mercaptopropanoic
acids
therapeutic use
carboxymethyl esters
esters
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7821086A
Other languages
English (en)
French (fr)
Other versions
FR2397401B1 (no
Inventor
Miguel Angel Ondetti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2397401A1 publication Critical patent/FR2397401A1/fr
Application granted granted Critical
Publication of FR2397401B1 publication Critical patent/FR2397401B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/18—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C327/00—Thiocarboxylic acids

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Indole Compounds (AREA)
  • Medical Treatment And Welfare Office Work (AREA)
FR7821086A 1977-07-14 1978-07-13 Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique Granted FR2397401A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81547277A 1977-07-14 1977-07-14

Publications (2)

Publication Number Publication Date
FR2397401A1 true FR2397401A1 (fr) 1979-02-09
FR2397401B1 FR2397401B1 (no) 1983-06-17

Family

ID=25217891

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7821086A Granted FR2397401A1 (fr) 1977-07-14 1978-07-13 Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique

Country Status (15)

Country Link
JP (1) JPS5419914A (no)
AU (1) AU522452B2 (no)
BE (1) BE869014A (no)
CA (1) CA1090354A (no)
CH (1) CH632490A5 (no)
DE (1) DE2830635A1 (no)
DK (1) DK149770C (no)
FR (1) FR2397401A1 (no)
GB (1) GB2001963B (no)
HU (1) HU177904B (no)
IE (1) IE47423B1 (no)
IT (1) IT1105098B (no)
NL (1) NL7807492A (no)
NO (1) NO146024C (no)
SE (1) SE7807821L (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0535042B1 (en) * 1990-06-22 1995-03-29 FISONS plc Angiotensis converting enzyme inhibitors
US20090029429A1 (en) * 2004-08-13 2009-01-29 Kaneka Corporation Process for Producing Optically Active 2-Substituent-Oxy-3-(4-Substituent-Oxyphenyl) Propionic Acid Derivative

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1527919A (fr) * 1967-03-23 1968-06-07 Nouveaux dérivés de l'acide salicylique
NL7300235A (no) * 1972-01-12 1973-07-16

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1527919A (fr) * 1967-03-23 1968-06-07 Nouveaux dérivés de l'acide salicylique
NL7300235A (no) * 1972-01-12 1973-07-16

Also Published As

Publication number Publication date
DE2830635C2 (no) 1988-06-23
IT1105098B (it) 1985-10-28
JPS6216943B2 (no) 1987-04-15
SE7807821L (sv) 1979-01-15
DE2830635A1 (de) 1979-02-01
GB2001963B (en) 1982-02-24
AU522452B2 (en) 1982-06-10
CA1090354A (en) 1980-11-25
BE869014A (fr) 1979-01-15
DK149770C (da) 1987-03-09
GB2001963A (en) 1979-02-14
IE781296L (en) 1979-01-14
NO146024B (no) 1982-04-05
NO146024C (no) 1982-07-14
DK149770B (da) 1986-09-29
NL7807492A (nl) 1979-01-16
AU3758878A (en) 1980-01-03
IE47423B1 (en) 1984-03-07
JPS5419914A (en) 1979-02-15
IT7850235A0 (it) 1978-07-10
CH632490A5 (fr) 1982-10-15
HU177904B (en) 1982-01-28
NO782429L (no) 1979-01-16
FR2397401B1 (no) 1983-06-17
DK315378A (da) 1979-01-15

Similar Documents

Publication Publication Date Title
FR2446832A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
FR2400517A1 (fr) Triazolo-2,4-benzodiazepines et leur utilisation therapeutique
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2416891A1 (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
FR2430411A1 (fr) Phenethanolamines et leur utilisation therapeutique
FR2406641A1 (fr) 2,6-diaminonebularines et leur application therapeutique
FR2417510A1 (fr) 9-amino- et imino-dibenzopyrannes et leur utilisation therapeutique
BE876157Q (fr) Medicament pour le traitement de l'acne
FR2446283A1 (fr) Phenoxyphenylpiperidines, leur preparation et leurs applications therapeutiques
FR2442836A1 (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur preparation et leur utilisation therapeutique
FR2430408A1 (fr) Phenethanolamines optiquement actives et leur utilisation therapeutique
FR2385682A1 (fr) Nouveaux 1-amino-indanes et leur utilisation comme medicaments
FR2398072A1 (fr) Acides et sels d'acides (n-carboxyalkyl-amino)-alcane-polyphosphoniques utilisables comme agents complexants
FR2375253A1 (fr) Preparations de g-lactones d'acides 7x-(alcoxycarbonyl)-6x -alkyl/halog 17-hydroxy-3-oxo-17a -pregn-4-ene-21-carboxyliques, des acides 21-carboxyliques correspondants, de leurs sels et esters, et leur utilisation therapeutique comme diuretiques
FR2375245A1 (fr) Acides carboxyphosphoniques utilisables pour le traitement d'eaux
FR2403353A1 (fr) Nouveaux derives de l'acide polyaspartique, leur preparation et leur utilisation dans des compositions cosmetiques
FR2397401A1 (fr) Esters carboxymethyliques d'acides mercaptopropanoiques, et leur utilisation therapeutique
FR2362852A1 (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
FR2415107A1 (fr) Derives de 5-phenethyl-2-oxazolidone, leur procede de preparation et leur application en therapeutique
FR2399406A1 (fr) Derives de perhydronaphtalenepentol et leur utilisation therapeutique
FR2392966A1 (fr) Nouveaux acides uree-bis(naphtalene-sulfoniques et naphtalene-carboxyliques), leurs sels pharmaceutiquement acceptables, et leur utilisation therapeutique
FR2446833A1 (fr) Octahydro-2h-pyrrolo(3,4-g)quinoleines et leur utilisation therapeutiques
FR2451375A1 (fr) 2-azaergolines et 2-aza-8 (ou 9) ergolenes et leur utilisation therapeutique
FR2363541A1 (fr) Acyloxy-n,n' diacylmalonamides et leur mode de preparation
FR2428047A1 (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique

Legal Events

Date Code Title Description
ST Notification of lapse